Top 10 stocks for today – 31st October 2022

  • India Infoline News Service |
  • 31 Oct, 2022 |
  • 8:29 AM
The Singapore Exchange's Nifty futures traded 193.5 points, or 1.08%, higher at 18,028, indicating that the stock market may begin the day higher on Monday. The following stocks may show price movement in today's trade. Check more hot stocks at:
  1. Maruti Suzuki:
Due to record sales, the automaker's consolidated net profit after tax increased by more than four times to Rs 2,112.5 crore in the second quarter.
  1. Vedanta:
Due to increasing expenses, mining firm Vedanta recorded a consolidated net profit after tax that fell by 53% to Rs 2690 crore for the three months that ended on September 30.
  1. Blue Dart:
On a consolidated basis, the company recorded a growth in total revenues of 17.95%, or Rs 1,325 crore, for the quarter ending in September 2022.
  1. NTPC:
Due to rising expenses, the state-run power company NTPC reported a more than 7% decline in its consolidated net profit for the September quarter of FY23, coming in at Rs 3,417.67 crore.
  1. Lupin:
The Nagpur Unit-2 injectable production facility of Lupin was inspected by the US FDA. A Pre-Approval Inspection (PAI) of the injectable facility was conducted.
  1. Hindustan Copper:
The company's Long-term rating of ICRA AA+ and Short-term rating of ICRA A1+ have both been reaffirmed by credit rating agency ICRA. The Long-Term Rating's outlook is stable.
  1. Bandhan Bank:
Compared to a loss of Rs3,009 crore in the same period last year, Bandhan Bank, a private company, declared a net profit of Rs 209 crore for the third quarter.
  1. Hero MotoCorp:
Hero MotoCorp, the largest two-wheeler manufacturer in the nation, reported significant double-digit growth in retail sales during the holiday season.
  1. Zydus Lifesciences:
The US Food and Drug Administration (USFDA) has given the business final permission to commercialise acetaminophen injection's 1,000 mg/100mL (10 mg/mL) single-dose vials.
  1. Dr Reddy’s Laboratories:
For the quarter that ended in September, Dr Reddy's Laboratories recorded a roughly 12% year-over-year (YoY) increase in consolidated net profit at Rs1,114 crore.

For feedback and suggestions, write to us at


Invest wise with Expert advice

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
ad IconAd Image

Most Read News

Article Image
  • 14 March, 2022 |
  • 7:03 AM

The US Federal committee's meeting will conclude on March 16, 2022.

Most Shared News

No Record Found